Fibrinogen Concentrates Market to Reach Valuation of US$ 700 Mn by 2031; High Volume Clinical Use in Coagulation Applications Bolsters Market Growth, TMR

- Emphasis on hemostatic resuscitation to reduce the number of hemorrhage-related deaths in the first hour of hospital admission fuels growth of the fibrinogen concentrates market

- Initiatives undertaken by product manufacturers for collaborations with the scientific community for improved patient outcomes cements growth of the fibrinogen concentrates market

News provided by

Transparency Market Research

Nov 09, 2021, 07:30 ET

ALBANY, N.Y., Nov. 9, 2021 /PRNewswire/ -- The expanding medical practice of use of fibrinogen concentrates for the management of severe bleeding episodes is a key factor fuelling the fibrinogen concentrates market. Fibrinogen concentrates are gaining popularity due to their precise dose of administration in place of whole blood for a desired level in the bloodstream.

The substantial evidence of tolerance of fibrinogen concentrate in patients with congenital fibrinogen deficiency (CFD) and its efficacy for treating bleeding episodes is another key factor driving the fibrinogen concentrates market. Fibrinogen concentrate has a favorable safety profile and served to be effective to treat bleeding in surgical and non-surgical situations.

Request Brochure of Fibrinogen Concentrates Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=63141

The fibrinogen concentrates market is estimated to clock CAGR of 5.7% from 2021- 2031.

Fibrinogen Concentrates Market – Key Findings of Report

Improved Survival Rate for Patients of Trauma-induced Coagulopathy Boosts Adoption

The early administration of fibrinogen concentrate is associated with improved survival rate for patients with critical injuries. In the ideal scenario, early administration of fibrinogen concentrate mostly occurs in trauma care before hospitalization. Fibrinogen concentrate is administered in a complex and time-sensitive environment to prevent fibrinogen depletion to promote rapid blood clot initiation and clot stability.

The growing incidence of trauma-induced coagulopathy (TIC) in critically injured and severely bleeding patients in emergency department (ED) admissions of hospitals that is related to increased mortality is increasing the demand for fibrinogen concentrates. In order to serve this, companies in the fibrinogen concentrates market are expanding their production capabilities for these products.

Request for Analysis of COVID-19 Impact on Fibrinogen Concentrates Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=63141

The growing evidence of early administration of fibrinogen supplementation associated with improved survival rate in patients of trauma is accentuating demand for fibrinogen concentrates. This is leading to the expanding demand for fibrinogen concentrate products in acute trauma care centers prior to hospitalization.

Significant Number of Hemorrhage-related Fatalities Drives Demand

Hemorrhage is related to significant number of deaths in the first hour of hospital admissions. This is leading to the growing emphasis on hemostatic resuscitation in pre-hospital settings and emergency care of battlefields. In particular, remote damage control resuscitation (RDCR) is growing popular within fibrinogen concentrate therapies. However, the availability and logistics challenges associated with hemostatic products that can be stored, transported, and used easily in tough external conditions is a challenge. This is driving manufacturers of fibrinogen concentrates to discover novel solutions.

Buy Fibrinogen Concentrates Market Research Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=63141&ltype=S

Besides this, the growing evidence of fibrinogen concentrates to reduce transfusion of blood products and increase survival rate of patients after severe trauma is driving R&D for improved fibrinogen concentrate products. Research collaborations that involve randomized controlled trials to assess how fibrinogen concentrates help to reduce proneness to bleeding and reduce transfusion requirements are underway.

Research Collaborations for Improved Patient Outcomes Gathers Steam

The increasing collaboration of manufacturers of fibrinogen concentrates with researchers, medical experts, and scientists for improved products is promising for the growth of fibrinogen concentrates market. For instance, Canadian Blood Services – an enterprise for lifesaving transfusion and transplantation products and services is gaining recognition for consistent improvement of patient quality of life.

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, Request for Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=63141

Such initiatives are supporting national studies, which suggest fibrinogen concentrate is equivalent to cryoprecipitate in controlled post-surgical bleeding.

The need to mitigate high incidence of thrombosis and disordered hemostasis associated with COVID-19 is also driving manufacturers for improved anticoagulation therapies. This is creating opportunities in the fibrinogen concentrates market.

Fibrinogen Concentrates Market – Growth Drivers

Clinical use of fibrinogen concentrates for the treatment of severe bleeding in patients suffering from congenital fibrinogen deficiency fuels the fibrinogen concentrates market
Collaborations of product manufacturers with the scientific community coupled with an array of recent product approvals boost the fibrinogen concentrates market

Fibrinogen Concentrates Market – Key Players

Some of the key players operating in the fibrinogen concentrates market are LFB GROUP, Octapharma AG, Shanghai RAAS, Green Cross Corp., and CSL Behring.

The fibrinogen concentrates market is segmented as follows;

Fibrinogen Concentrates Market, by Application

General Coagulation Management
Surgery
Others

Fibrinogen Concentrates Market, by End User

Hospitals
ASCs
Others

Fibrinogen Concentrates Market, by Region

North America

U.S.
Canada

Europe

Germany
U.K
France
Italy
Spain
Rest of Europe

Asia Pacific

China
India
Japan
Australia & New Zealand
Rest of Asia Pacific

Latin America

Brazil
Mexico
Rest of Latin America

Middle East & Africa

GCC Countries
South Africa
Rest of Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Hemostasis Diagnostics Market: According to the report, the global hemostasis diagnostics market was valued at US$ 2.3 Bn in 2018 and is anticipated to expand at a CAGR of 8.5% from 2019 to 2027, rise in prevalence of blood clotting disorders, high prevalence of cardiovascular diseases are projected to drive the global hemostasis diagnostics market during the forecast period

Bovine Blood Plasma Derivatives Market: Growing usage of blood plasma products in the food industry, which is experiencing an extended demand for food products with nutritious values, is the primary driver of the bovine blood plasma derivatives market.

Fibrinogen Testing Reagents Market: Rising cases of chronic illnesses, accidents, and lifestyle diseases like diabetes are expected to drive significant growth for the fibrinogen testing reagents market, the blood-assessment including the tests to determine blood plasma promise significant opportunities for players in the fibrinogen testing reagents market in the near future.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/fibrinogen-concentrates-market.htm